Business Standard

Zydus Cadila receives final approval for Voriconazole Tablets

Image

Capital Market

From USFDA

Zydus Cadila has received final approval from the USFDA to market Voriconazole Tablets in strengths 50 mg and 200 mg. The drug will be produced at the group's formulations manufacturing facility at Baddi.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 25 2016 | 12:22 PM IST

Explore News